Smith Mark Douglas (CIK 1756253) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Sell JAZZ (14 shares), Sell JAZZ (1,692 shares), Buy JAZZ (1,605 shares), Buy PHR (19,290 shares), Sell JAZZ (1,157 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 14 | $3,425 |
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,692 | $408,432 |
| 2026-08-07 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 1,605 | $0 |
| 2026-06-26 | Phreesia, Inc. (PHR) | Director | Buy | 19,290 | $184,991 |
| 2026-06-17 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,157 | $266,746 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,805 | $200,806 |
| 2025-07-03 | Phreesia, Inc. (PHR) | Director | Buy | 7,000 | $32,970 |
| 2025-07-03 | Phreesia, Inc. (PHR) | Director | Sell | 7,000 | $203,000 |
| 2025-06-27 | Phreesia, Inc. (PHR) | Director | Buy | 6,700 | $184,987 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02